Metraipolis › archive › dc_21365cd52b1e

Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study — Europe PMC PMID:41131329

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41131329
DOI
10.1038/s41433-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-09T02:48:20.268Z
SHA-256 of the archived text
2f1c7bf6011b6a0459202772e22edfc40fde9a10c2ad061a96e0a12c98ea0f09
Stable URL of this page
https://metraipolis.com/documento/dc_21365cd52b1e

How to cite

Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study — Europe PMC PMID:41131329 — Europe PMC (en), https://europepmc.org/article/MED/41131329 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_21365cd52b1e (Metraipolis archive dc_21365cd52b1e, sha256 2f1c7bf6011b6a0459202772e22edfc40fde9a10c2ad061a96e0a12c98ea0f09)
BibTeX
@misc{dc21365cd52b1e,
  title = {Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study — Europe PMC PMID:41131329},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41131329},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_21365cd52b1e; sha256 2f1c7bf6011b6a0459202772e22edfc40fde9a10c2ad061a96e0a12c98ea0f09},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41131329. Agents can read the archived copy with the MCP tool read_document.